USPH U S PHYSICAL THERAPY INC /NV
Services-Health Services · NYSE · SEC CIK 885978 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.4%
TTM net income YoY-32.5%
TTM EPS YoY-156.1%
Revenue 3-yr CAGR12.3%
Net income 3-yr CAGR-0.1%
Margins
Gross margin18.8%
Operating margin9.1%
Net margin3.6%
FCF margin8.2%
EBITDA margin11.7%
Returns
ROE6.5%
ROA2.4%
ROIC (approx.)9.1%
Asset turnover0.67x
Leverage & solvency
Liabilities / assets39.2%
Debt / equity0.57x
Current ratio1.42x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.95x
Accruals ratio-4.7%
Payout ratio—
Capex / revenue2.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $222.56M | $214.06M | $198.29M | $202.73M | $197.13M | $197.34M | $183.79M | $180.45M |
| Gross profit | $43.03M | $41.94M | $32.75M | $40.13M | $36.87M | $41.62M | $31.07M | $32.53M |
| SG&A expense | $17.83M | $19.00M | $18.27M | $18.12M | $17.41M | $17.48M | $16.25M | $15.57M |
| Operating income | $25.10M | $21.95M | $12.48M | $16.77M | $25.33M | $24.94M | $19.64M | $19.65M |
| Pretax income | $21.56M | $19.05M | $10.56M | $14.96M | $22.88M | $22.65M | $17.33M | $18.32M |
| Income tax | $3.97M | $4.16M | $2.41M | $5.78M | $5.23M | $4.93M | $3.86M | $5.83M |
| Net income | $11.04M | $9.90M | $5.04M | $4.15M | $13.14M | $12.39M | $9.90M | $9.24M |
| EBITDA | $30.97M | $27.57M | $18.48M | $21.40M | $30.82M | $30.68M | $25.51M | $25.34M |
| EPS (basic) | -1.04 | 0.25 | -0.12 | — | 0.48 | 0.58 | 0.80 | — |
| EPS (diluted) | -1.04 | 0.25 | -0.12 | — | 0.48 | 0.58 | 0.80 | — |
| Dividends declared per share | 0.46 | 0.46 | 0.46 | 0.45 | 0.45 | 0.45 | 0.45 | 0.44 |
| Weighted avg. shares (diluted) | 14.93M | 15.07M | 15.17M | — | 15.20M | 15.20M | 15.13M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $38.23M | $24.89M | $28.44M | $35.57M | $31.10M | $34.09M | $39.18M | $41.36M |
| Receivables | $63.22M | $69.60M | $69.08M | $64.25M | $67.63M | $65.96M | $64.76M | $59.04M |
| Current assets | $154.76M | $139.68M | $139.11M | $139.99M | $138.44M | $140.53M | $145.35M | $137.58M |
| PP&E, net | $42.21M | $40.43M | $38.62M | $35.65M | $34.22M | $32.12M | $32.76M | $32.14M |
| Goodwill | $732.80M | $716.53M | $715.87M | $692.39M | $692.39M | $677.60M | $674.39M | $667.15M |
| Intangibles | $180.37M | $176.55M | $179.82M | $172.86M | $176.43M | $175.63M | $177.33M | $179.31M |
| Total assets | $1.30B | $1.25B | $1.24B | $1.20B | $1.20B | $1.18B | $1.18B | $1.17B |
| Current liabilities | $109.22M | $109.91M | $117.30M | $139.04M | $115.08M | $118.84M | $123.80M | $116.28M |
| Short-term debt | $4.42M | $4.56M | $10.80M | $9.87M | $8.80M | $8.17M | $9.26M | $11.00M |
| Long-term debt | $241.69M | $215.46M | $194.04M | $152.59M | $151.46M | $151.91M | $157.24M | $142.53M |
| Total debt | $246.10M | $220.02M | $204.84M | $162.46M | $160.26M | $160.08M | $166.50M | $153.53M |
| Total liabilities | $508.36M | $482.22M | $459.19M | $433.81M | $413.83M | $414.01M | $420.68M | $408.42M |
| Shareholders' equity | $429.30M | $448.66M | $468.98M | $476.43M | $503.57M | $500.75M | $497.26M | $488.93M |
| Net debt | $207.88M | $195.13M | $176.40M | $126.89M | $129.16M | $126.00M | $127.31M | $112.17M |
| Cash flow statement | ||||||||
| Operating cash flow | $25.72M | $34.37M | $3.81M | $24.93M | $19.94M | $34.86M | -$4.67M | $19.41M |
| Capital expenditure | $5.07M | $5.36M | $5.37M | $3.93M | $4.32M | $3.25M | $2.58M | $2.49M |
| Free cash flow | $20.65M | $29.01M | -$1.56M | $21.01M | $15.62M | $31.61M | -$7.25M | $16.92M |
| Investing cash flow | -$26.48M | -$6.41M | -$39.80M | -$5.44M | -$11.94M | -$12.71M | -$6.63M | -$94.85M |
| Financing cash flow | $14.09M | -$31.52M | $28.86M | -$15.02M | -$10.99M | -$27.25M | $9.12M | -$153,000 |
| Depreciation & amortization | $5.87M | $5.62M | $6.00M | $4.63M | $5.50M | $5.74M | $5.87M | $5.68M |
| Stock-based compensation | $3.00M | $2.40M | $2.31M | $2.12M | $2.30M | $2.00M | $1.77M | $1.99M |
| Dividends paid | $6.86M | — | — | $6.84M | $6.84M | — | — | $6.64M |
| Share buybacks | $0 | — | — | $5.57M | $0 | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.